Podcast

In this episode of Unscripted, AMCP speaks with Dr. Harrison Nguyen, a double board-certified dermatologist and health economist, about the true scope of psoriasis. From overlooked symptoms and high-impact areas to the systemic nature of the disease, Dr. Nguyen explains why a personalized treatment strategy is essential. He also explores the economic case for early intervention and access to advanced therapies.

In this episode of Unscripted – The AMCP Podcast, Tonja Johnson – founder of the Beautifully Unblemished Vitiligo Support Group – shares her personal journey with vitiligo, from diagnosis and frustration to advocacy and empowerment. In recognition of World Vitiligo Day, this conversation explores the physical, emotional, and social challenges of living with the condition, the ongoing stigma and mental health impact, and the urgent need for health plans to treat vitiligo as more than cosmetic. This episode highlights how community, awareness, and managed care can come together to improve the lives of those affected.

Join us on this episode of Unscripted, the AMCP Podcast, as we explore the emerging role of artificial intelligence in managed care pharmacy. Our guest, Joe Honcz, RPh, MVA, MBA and Senior Vice President of Market Access at Petauri, shares insights from his time at Aetna’s Innovation Lab through to today’s cutting-edge applications—from AI-powered health concierges to streamlined prior authorizations and precision drug discovery. Discover how AI is transforming efficiency, patient empowerment, and the future of pharmacy practice.

Listen to the final of a three-part podcast on a new, non-pharmacological treatment for Chronic Idiopathic Constipation. Hear from our experts Dr. Christine Frissora, Gastroenterologist and Associate Professor of Clinical Medicine at NY Presbyterian Cornell University Medical Center, and Dr. Ken Schaecher, Chief Medical Officer emeritus at University of Utah Health Plans, Chief Medical Officer at a regional health plan, and practicing general internal medicine specialist.

AMCP Unscripted discusses a new, non-pharmacological treatment for chronic idiopathic constipation with Dr. Christine Frissora, gastroenterologist and associate professor of clinical medicine, at The NY Presbyterian Cornell University Medical Center and Dr. Ken Schaecher, chief medical officer emeritus, University of Utah Health Plans and chief medical officer at a regional health plan and practicing general internal medicine specialist.

AMCP Unscripted discusses a new, non-pharmacological treatment for Chronic Idiopathic Constipation with Dr. Christine Frissora, gastroenterologist and associate professor of clinical medicine, at The NY Presbyterian Cornell University Medical Center and Dr. Ken Schaecher, chief medical officer emeritus, University of Utah Health Plans and chief medical officer at a regional health plan and practicing general internal medicine specialist.

In this episode of Unscripted, the AMCP Podcast, we welcome Casey Koch, PharmD, Clinical Pharmacy Coordinator at Select Health. Join us as we explore the evolving landscape of inflammatory bowel disease (IBD), including the latest treatment advancements, guideline updates, and the role of managed care pharmacy in optimizing patient outcomes. From biologics to biosimilars, personalized medicine, and health disparities, we dive deep into the complexities of IBD management and what the future holds for patients and providers alike.

On this Unscripted podcast, Host Fred Goldstein invites Andrew McKechnie from the Tiber Creek Group, and AMCP Associate Vice President, Congressional Affairs Adam Colborn and Associate Vice President, Regulatory Affairs Geni Tunstall to discuss upcoming Cabinet confirmations, drug policy, biosimilars, 340B, and more.

Host Fred Goldstein invites Elizabeth Powers, Vice President, General Manager of Regulatory Science and Study Innovation at IQVIA to discuss real-world evidence (RWE).

Host Fred Goldstein invites Brian Hilberdink, President, Executive Vice President North America and Douglas Maslin, MD, Global Principal Medical Advisor to discuss LEO Pharma and their involvement with AMCP.